CNTO 148

DRUG2 trials

Sponsors

Janssen Pharmaceutical K.K.

Conditions

Rheumatoid Arthritis

Phase 3

A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

CompletedNCT00727987

Janssen Pharmaceutical K.K.Rheumatoid Arthritis

Start: 2008-05-31End: 2011-12-31Updated: 2013-05-23

A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)

CompletedNCT00771251

Janssen Pharmaceutical K.K.Rheumatoid Arthritis

Start: 2008-05-31End: 2011-10-31Updated: 2015-11-03